Define ACLF (EASL-CLIF and APASL), treat precipitants including alcoholic hepatitis and HBV flare, support organs, and decide on transplant or futility.
At the bedside
- 1
Identify precipitant
Infection (SBP, pneumonia, UTI), alcoholic hepatitis, HBV reactivation/flare, HEV/HAV superinfection, DILI, GI bleed. Culture all sites, diagnostic paracentesis.
- 2
Grade
Count organ failures (liver, kidney, brain, coagulation, circulation, respiration) using CLIF-C OF; calculate CLIF-C ACLF score or APASL AARC score.
- 3
Treat infection early
Empirical antibiotics according to local resistance (nosocomial: broader cover); start within 1 h if septic shock.
- 4
Alcoholic hepatitis
Maddrey DF ≥ 32 or MELD > 20 without infection/bleeding/AKI: prednisolone 40 mg/day; Lille at day 7 (≥ 0.45 = stop). Abstinence counselling.
- 5
HBV
Start tenofovir or entecavir immediately in HBV-related ACLF.
- 6
Organ support
Albumin for volume, noradrenaline ± terlipressin, CRRT, ventilation; HE care; avoid nephrotoxins and sedatives.
- 7
Transplant evaluation
Early referral; ACLF-2/3 have 28-day mortality 30-80% without transplant.
- 8
Reassess at day 3-7
Day 3-7If ≥ 4 organ failures or CLIF-C ACLF > 70 after 3-7 days of full support and not a transplant candidate, discuss limitation/palliation.
Severe alcoholic hepatitis
Prednisolone
- Dose
- 40 mg once daily for 28 days
Stop at day 7 if Lille ≥ 0.45.
HBV-related ACLF
Tenofovir disoproxil fumarate / entecavir
- Dose
- Tenofovir DF 300 mg daily (or entecavir 0.5 mg daily)
EASL-CLIF ACLF grades (simplified)
| Grade | Organ failures | Approx. 28-day mortality |
|---|---|---|
| No ACLF | None, or single non-kidney OF with creatinine < 1.5 and no HE | ~5% |
| ACLF-1 | Single kidney failure, or single other OF with creatinine 1.5-1.9 mg/dL and/or grade I-II HE | ~20-25% |
| ACLF-2 | Two organ failures | ~30-35% |
| ACLF-3 | Three or more organ failures | ~70-80% |
References
- 1
- 2
- 3
- 4
ACLF approach
Step 1 of ~7
Count organ failures; CLIF-C ACLF / AARC score
Based on European Association for the Study of the Liver. Educational use; follow local protocol.
Pathophysiology
Systemic inflammation driven by PAMPs (infection, translocation) and DAMPs (alcohol, viral hepatitis) causes immunopathology, mitochondrial dysfunction and organ failure on a background of portal hypertension and immune paresis.
Evidence
- EASL 2023 ACLF guideline: definitions, organ support, transplant and futility [EASL 2023].
- APASL 2019 update, with AARC score widely used in Asia [Sarin 2019].
- Lille model: non-response to steroids (≥ 0.45) predicts poor survival [Louvet 2007].
Controversies
- G-CSF, plasma exchange and extracorporeal liver support in ACLF; transplant in ACLF-3.
🇮🇳 India notes
- APASL criteria were developed largely from Asian (including Indian) cohorts with alcohol and HBV/HEV precipitants.
- Cost of transplant and limited deceased-donor organs mean early goals-of-care discussions are important in India.
References
- 1
- 2
- 3
- 4
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

